posted
Check it out. This stock has decent volume and is at a new low as of today. The spread is decent and will rocket with a PR. Its down but should make an easy flip in the near future.Look at the year chart and you will always see it bounces up after a dip NO MATTER WHAT AND THATS A FACT. ----------------------------------------------- This is not a pump thread just watch it will happen.IMO
Also they should be updating people with a PR in the future regarding this dividend. Some PR from two months ago. The dividend hasn't happend yet but when it does people will BUY like crazy. IMO
Medify Solutions Limited (Pink Sheets: MFYS) announces Extraordinary Shareholders Dividend GATESHEAD, UK, May 11 /PRNewswire-FirstCall/ - Medify Solutions Limited (Pink Sheets: MFYS) is to grant a 'like for like' extraordinary share dividend to all existing company shareholders. Due to the confirmed interest in Medify Solutions Limited products in Europe and Asia, Medify will be creating subsidiaries to manage and deliver the operational and service aspects of the business based within the geographical regions of operations.
The company will issue the formal notification in writing to all shareholders as to the date of the issuance of this extraordinary dividend. It is planned in the first instance, and in near future, to float on a North American, European or UAE Exchange. By floating these subsidiaries, not only will the proven business model be reciprocated, but it will allow security and the prerequisite finance to grow the business globally without impacting on shareholders or their dilution.
In simple terms, the shareholder will be granted through dividend the equivalent numbers of shares in the floated subsidiary, for every share held in Medify Solutions Limited (MFYS), at an announced date prior to the float. For example, 1 million shares held in Medify Solutions Limited (MFYS) prior to the float will yield a dividend of 1 million shares free of charge in the International floated subsidiary and 1 million shares free of charge in the Asian floated subsidiary.
Jonathan Bryant, Executive Chairman, said: 'This announcement is the culmination of extensive planning and is designed to ensure the success, both financially and operationally of all of Medify Solutions Limited subsidiaries and the core business. Furthermore this move allows us to reward the shareholders who have believed and supported Medify from its concept. This is truly exciting news and a major progression for the company and shareholders and I hope that everyone associated shares this view. Strong foundations, sustainability, expansion and revenue delivery, reward for our customers and shareholders alike.' Any questions regarding this extraordinary dividend can be addressed to our corporate email at Press*medifysolutions.com.
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words 'estimate,' 'project,' 'intends,' 'expects,' 'believes,' and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the 'safe-harbour' provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of StockTargets, see 'Risk Factors' in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
